November 17, 2020 10:45 AM EST
Deals

Roche inks $308.6M col­lab­o­ra­tion deal with Lead Phar­ma, fo­cus­ing on im­mune-me­di­at­ed dis­ease

Nicole DeFeudis

Editor

Roche is wad­ing deep­er in­to the field of im­mune-me­di­at­ed dis­ease with a €260 mil­lion ($308.6 mil­lion) col­lab­o­ra­tion deal with Nether­lands …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

A service from the Financial Times